Characterization of a dipeptide motif regulating IFN-γ receptor 2 plasma membrane accumulation and IFN-γ responsiveness

Journal of Immunology

Volumn 173, Issue 6, 2004, Pages 3991-3999

  Rosenzweig, Sergio D ^a,c   Schwartz, Owen M ^a   Brown, Margaret R ^b   Leto, Thomas L ^a   Holland, Steven M ^a,d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^d MSC 1886 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; DIPEPTIDE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR 1; GAMMA INTERFERON RECEPTOR 2; ISOLEUCINE; JANUS KINASE 2; LEUCINE; POLYPEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DELETION MUTANT; DNA FLANKING REGION; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNITY; MUTATION; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 4644275692     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.6.3991     Document Type: Article

References (33)

1. Nelson, W. J., and C. Yeaman. 2001. Protein trafficking in the exocytic pathway of polarized epithelial cells. Trends Cell Biol. 11:483.
2. Bonifacino, J. S., and L. M. Traub. 2003. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu. Rev. Biochem. 72:395.
3. Bach, E. A., M. Aguet, and R. D. Schreiber. 1997. The IFNγ receptor: a paradigm for cytokine signaling. Annu. Rev. Immunol. 15:563.
4. Farrar, M. A., J. Fernandez-Luna, and R. D. Schreiber. 1991. Identification of two regions within the cytoplasmic domain of the human interferon-γ receptor required for function. J. Biol. Chem., 266:19626.
5. Jouanguy, E., S. Lamhamedi-Cherradi, D. Lammas, S. E. Dorman, M. C. Fondaneche, S. Dupuis, R. Doffinger, F. Altare, J. Girdlestone, J.-F. Emile, et al. 1999. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 21:370.
6. Pernis, A., S. Gupta, K. J. Gollob, E. Garfein, R. L. Coffman, C. Schindler, and P. Rothman. 1995. Lack of interferon-γ receptor β chain and the prevention of interferon-γ signaling in Th1 cells. Science 269:246.
7. Bach, E. A., S. J. Szabo, A. S. Dighe, A. Ashkenazi, M. Aguet, K. M. Murphy, and R. D. Schreiber. 1995. Ligand-induced autoregulation of IFN-γreceptor β chain expression in T helper cell subsets. Science 270:1215.
8. Sakatsume, M., and D. S. Finbloom. 1996. Modulation of expression of the IFN-γ receptor β-chain controls responsiveness to IFN-γ in human peripheral blood T cells. J. Immunol., 156:4160.
9. Larkin, J., III, H. M. Johnson, and P. S. Subramaniam. 2000. Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFNγ receptor complex following activation by IFNγ. J. Interferon Cytokine Res. 20:565.
10. Bernabei, P., A. Allione, L. Rigamonti, M. Bosticardo, G. Losana, I. Borghi, G. Forni, and F. Novelli. 2001. Regulation of interferon-γ receptor (IFN-γR) chains: a peculiar way to rule the life and death of human lymphocytes. Eur. Cytokine Network 12:6.
11. Bernabei, P., E. Coccia, L. Rigamonti, M. Bosticardo, G. Losana, G. Forni, S. Pestka, C. D. Krause, A. Battistini, and F. Novelli. 2001. Interferon-γ receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation and death. J. Leukocyte Biol. 70:950.
12. Rigamonti, L., S. Ariotti, G. Losana, R. Gradini, M. A. Russo, E. Jouanguy, J.-L. Casanova, G. Forni, and F. Novelli. 2000. Surface expression of the IFN-γR2 chain is regulated by intracellular trafficking in human T lymphocytes. J. Immunol. 164:201.
13. Dorman, S. E., and S. M. Holland. 1998. Mutation in the signal-transducing chain of the interferon-γ receptor and susceptibility to mycobacterial infection. J. Clin. Invest. 101:2364.
14. Shuai, K., C. Schindler, V. R. Prezioso, and J. E. Darnell, Jr. 1992. Activation of transcription by IFN-γ: tyrosine phosphorylation of 91-kD DNA binding protein. Science 258:1808.
15. Chianelli, M., A. Signore, R. Hicks, R. Testi, M. Negri, and P. C. L. Beverley. 1993. A simple method for the evaluation of receptor binding capacity of modified cytokines. J. Immunol. Methods 166:177.
16. Novelli, F., A. Allione, P. Bernabei, L. Rigamonti, and G. Forni. 1997. Anti-blasticc chemotherapy drugs up-modulate interferon-γ receptor expression on human malignant T cells. Cancer Detect. Prev. 21:191.
17. Marsters, S. A., D. Pennica, E. Bach, R. D. Schreiber, and A. Ashkenazi. 1995. Interferon γ signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain. Proc. Natl. Acad. Sci. USA 92:5401.
18. Wang, B., I. Andre, A. Gonzalez, J. D. Katz, M. Aguet, C. Benoist, and D. Mathis. Interferon-γ impacts at multiple points during progression of autoimmune diabetes. 1997. Proc. Natl. Acad. Sci. USA 94:13844.
19. Allimi, E., S. Huang, M. P. Brazillet, and J. Charreire. 1996. Experimental autoimmune thyroiditis (EAT) in mice lacking the IFN-γ receptor gene. Eur. J. Immunol., 28:201.
20. + myeloid cells. J. Immunol. 163:3503.
21. Zhang, G. X., B. G. Xiao, X. F. Bai, P. H. van der Meide, A. Orn, and H. Link. 1999. Mice with IFN-γ receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis. J. Immunol. 162:3775.
22. Serreze, D. V., C. M. Post, H. D. Chapman, E. A. Johnson, B. Lu, and P. B. Rothman. 2000. Interferon-γ receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes 9:2007.
23. Zhu, Y., H. G. Ljunggren, E. Mix, H. L. Li, A. M. van der Meide Pelhassan, B. Winblad, and J. Zhu. 2001. Suppression of autoimmune neuritis in IFN-γ receptor deficient mice. Exp. Neurol. 169:472.
24. Dighe, A. S., E. Richards, L. J. Old, and R. D. Schreiber. 1994. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors. Immunity 1:447.
25. Novelli, F., M. M. D'Elios, P. Bernabei, L. Ozman, L. Rigamonti, F. Allmerigogna, G. Forni, and G. Del Prete. 1997. Expression and role in apoptosis of the α- and β-chaon of the IFN-γ receptor on human Th1 and Th2 clones. J. Immunol. 159:206.
26. Kaplan, D. H., V. Shankaran, A. S. Dighe, E. Stockert, M. Aguet, L. J. Old, and R. D. Schreiber. 1998. Demonstration of an interferon-γ dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95:7556.
27. Beatty, G. L., and Y. Paterson. 2001. Regulation of tumor growth by IFN-γ in cancer immunotherapy. Immunol. Res. 24:201.
28. Ikeda, H. L. J. Old, and R. D. Schreiber. 2002. The roles of IFNγ protection against tumor development and cancer inmunoediting. Cytokine Growth Factor Rev. 13:95.
29. Kirchhausen, T. 2002. Clathrin adaptors really adapt. Cell 109:413.
30. Bach, E. A., W. Tanner, S. Marsters, A. Ashkenazi, M. Aguet, A. S. Shaw, and R. D. Schreiber. 1996. Ligand-induced assembly and activation of the γ interferon receptor in intact cells. Mol. Cell. Biol. 16:3214.
31. Govers, R., T. ten Broeke, P. van Kerkhof, A. L. Schwartz, and G. J. Strous. 1999. Identification of a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth hormone receptor. EMBO J. 18:28.
32. Strous, G. J., and R. Govers. The ubiquitin-proteasome system and endocytosis. J. Cell Sci. 112:1417.
33. Rosenzweig, S. D., S. E. Dorman, G. Uzel, S. Shaw, A. Scurlock, M. R. Brown, R. H. Buckley, and S. M. Holland. 2004. A novel mutation in IFN-γ receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J. Immunol. 173:4000.